Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T21:02:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH transition in terminology, saying “Super Intelligence” will be used in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T22:08:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T20:56:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T21:00:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown for the study record, including a minimal HTML structure and the '403 Forbidden' message, indicating an access-restricted view rather than an update to the study data.
    Difference
    18%
    Check dated 2026-09-19T20:33:26.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, replacing the previous v3.6.5, signaling a new release of the page’s content and UI. This change does not modify study details or user actions.
    Difference
    0.0%
    Check dated 2026-08-29T19:09:45.000Z thumbnail image

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.